Reply to corbeil et al.: Dedifferentiation and multipotency

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 15, 2014, Pages

  Kusaba, Tetsuro ^a,b   Humphreys, Benjamin D ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN;

CELL DEDIFFERENTIATION; CELL POPULATION; COLON; COLON MUCOSA; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; ISCHEMIA; KIDNEY; KIDNEY PROXIMAL TUBULE; LETTER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STEM CELL; UPREGULATION;

CELL DIFFERENTIATION; HUMANS; KIDNEY; KIDNEY TUBULES, PROXIMAL;

EID: 84898822560     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1401733111     Document Type: Letter

References (5)

1. Corbeil D, Fargeas CA, Jászai J (2014) CD133 might be a pan marker of epithelial cells with dedifferentiation capacity. Proc Natl Acad Sci USA 111:E1451-E1452.
2. Kusaba T, Lalli M, Kramann R, Kobayashi A, Humphreys BD (2014) Differentiated kidney epithelial cells repair injured proximal tubule. Proc Natl Acad Sci USA 111(4):1527-1532.
3. Shmelkov SV, et al. (2008) CD133 expression is not restricted to stem cells, and both CD133+ and CD133-metastatic colon cancer cells initiate tumors. J Clin Invest 118(6): 2111-2120.
4. Angelotti ML, Lazzeri E, Lasagni L, Romagnani P (2010) Only anti-CD133 antibodies recognizing the CD133/1 or the CD133/2 epitopes can identify human renal progenitors. Kidney Int 78(6):620-621, author reply 621.
5. Tata PR, et al. (2013) Dedifferentiation of committed epithelial cells into stem cells in vivo. Nature 503(7475): 218-223.